Peripheral inflammation mediates midbrain Lrrk2 kinase activity via Rab32 expression
Abstract:
Mutations that increase leucine-rich repeat kinase 2 (LRRK2) activity confer significant risk for Parkinson's disease (PD), yet incomplete disease penetrance suggest additional factors are required to manifest disease. We recently identified RAB32 Ser71Arg as a Mendelian gene for PD. Here, we establish Rab32 as a key mediator linking peripheral inflammation to Lrrk2 activation. We show that Rab32 and Rab38 expression are modestly, but inversely, correlated with their homolog Rab29. In vivo , peripheral lipopolysaccharide (LPS)-induced inflammation selectively induced Rab32 expression in midbrain Iba1 + microglia but not dopaminergic neurons, where it localized to Lamp1 + lysosomal compartments and correlated with Lrrk2 kinase activity. LPS similarly induces Rab32 expression in human induced pluripotent stem cell-derived microglia, demonstrating a unified biological response to inflammation across species. Promoter analysis identified Tfe3, a master regulator of lysosomal biogenesis and autophagy, as a key driver of Rab32 expression induced Lrrk2 kinase activation. During inflammation, Tfe3 translocated to the nucleus of midbrain Iba1 + microglia to induce Rab32 expression and Lrrk2 kinase activity. Knockdown of Tfe3, but not Tfeb, mitigates these effects, establishing Rab32 as a physiological rheostat of Lrrk2 activity. This mechanistic pathway enables peripheral inflammation to modulate LRRK2 activity and highlights Rab32/Tfe3 as a therapeutic targeting for neuroprotection in PD.
Insights
Peripheral inflammation triggers Rab32 expression in microglia, activating Lrrk2 kinase. This pathway links inflammation to Parkinson's disease risk, highlighting Rab32/Tfe3 as potential therapeutic targets.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- Mutations in leucine-rich repeat kinase 2 (LRRK2) increase Parkinson's disease (PD) risk, but incomplete penetrance indicates other factors are involved.
- Rab32 Ser71Arg was recently identified as a Mendelian gene for PD, suggesting a role for Rab32 in disease pathogenesis.
Purpose of the Study:
- To establish Rab32 as a mediator linking peripheral inflammation to Lrrk2 activation in Parkinson's disease.
- To investigate the role of Tfe3 in regulating Rab32 expression and Lrrk2 activity during inflammation.
Main Methods:
- In vivo studies using lipopolysaccharide (LPS) to induce peripheral inflammation in mice.
- Analysis of Rab32 expression in microglia and dopaminergic neurons.
- Utilizing human induced pluripotent stem cell-derived microglia to assess species-conserved responses.
- Promoter analysis to identify regulatory elements controlling Rab32 expression.
- Investigating the nuclear translocation of Tfe3 in response to inflammation.
Main Results:
- Peripheral LPS-induced inflammation selectively increased Rab32 expression in midbrain microglia, correlating with Lrrk2 kinase activity.
- LPS induced Rab32 expression in human microglia, indicating a conserved inflammatory response.
- Tfe3 was identified as a key driver of LPS-induced Rab32 expression and Lrrk2 activation.
- Tfe3 nuclear translocation in microglia during inflammation enhanced Rab32 expression and Lrrk2 activity.
- Knockdown of Tfe3 mitigated inflammation-induced Rab32 expression and Lrrk2 activation.
Conclusions:
- Rab32 acts as a crucial mediator linking peripheral inflammation to Lrrk2 activation in Parkinson's disease.
- The Rab32/Tfe3 pathway represents a novel mechanism by which inflammation modulates Lrrk2 activity.
- Targeting Rab32 and Tfe3 offers a potential therapeutic strategy for neuroprotection in Parkinson's disease.
Related Concept Videos
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


